Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

Starace F, Ammassari A, Trotta MP, Murri R, De Longis P, Izzo C, Scalzini A, d'Arminio Monforte A, Wu AW, Antinori A; AdICoNA Study Group. NeuroICoNA Study Group.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S136-9. Review.

PMID:
12562037
2.

Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy.

Bouhnik AD, Préau M, Vincent E, Carrieri MP, Gallais H, Lepeu G, Gastaut JA, Moatti JP, Spire B; MANIF 2000 Study Group.

Antivir Ther. 2005;10(1):53-61.

PMID:
15751763
4.

Social support and medication adherence in HIV disease in KwaZulu-Natal, South Africa.

Ncama BP, McInerney PA, Bhengu BR, Corless IB, Wantland DJ, Nicholas PK, McGibbon CA, Davis SM.

Int J Nurs Stud. 2008 Dec;45(12):1757-63. doi: 10.1016/j.ijnurstu.2008.06.006. Epub 2008 Jul 24.

PMID:
18653188
5.

Sleep disturbance and depression as barriers to adherence.

Phillips KD, Moneyham L, Murdaugh C, Boyd MR, Tavakoli A, Jackson K, Vyavaharkar M.

Clin Nurs Res. 2005 Aug;14(3):273-93.

PMID:
15995155
6.

Depression, social support and adherence to highly active antiretroviral therapy in people living with HIV/AIDS.

Gibbie T, Hay M, Hutchison CW, Mijch A.

Sex Health. 2007 Dec;4(4):227-32.

PMID:
18082064
7.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
8.

Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, Vecchiet J, D'Arminio Monforte A, Wu AW, Antinori A; AdICoNA Study Group.

J Acquir Immune Defic Syndr. 2002 Dec 15;31 Suppl 3:S123-7. Review.

PMID:
12562034
11.

[Impact of demographic and psychosocial factors on adherence to antiretroviral treatment].

Ruiz-Pérez I, Olry de Labry-Lima A, Prada-Pardal JL, Rodríguez-Baño J, Causse-Prados M, López-Ruz MA, Martín-Rico P, del Arco-Jiménez A, Pasquau-Liaño J, de la Torre-Lima J, López-Gómez M, Muñoz-Roca N, Marcos-Herrero M, Muñoz I, Morales-Rojas D.

Enferm Infecc Microbiol Clin. 2006 Jun-Jul;24(6):373-8. Spanish.

PMID:
16792939
12.

An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.

Bader A, Kremer H, Erlich-Trungenberger I, Rojas R, Lohmann M, Deobald O, Lochmann R, Altmeyer P, Brockmeyer N.

Med Sci Monit. 2006 Dec;12(12):CR493-500. Epub 2006 Nov 23.

PMID:
17136004
13.

Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.

Royal SW, Kidder DP, Patrabansh S, Wolitski RJ, Holtgrave DR, Aidala A, Pals S, Stall R.

AIDS Care. 2009 Apr;21(4):448-55. doi: 10.1080/09540120802270250.

PMID:
19401865
14.

Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice.

Stone VE.

Clin Infect Dis. 2001 Sep 15;33(6):865-72. Epub 2001 Aug 13. Review.

PMID:
11512092
15.

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.

Antivir Ther. 2004 Jun;9(3):407-14.

PMID:
15259903
16.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network.

Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70.

PMID:
16061785
17.

Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.

Reynolds NR, Testa MA, Marc LG, Chesney MA, Neidig JL, Smith SR, Vella S, Robbins GK; Protocol Teams of ACTG 384, ACTG 731 and A5031s.

AIDS Behav. 2004 Jun;8(2):141-50.

PMID:
15187476
18.

Symptom management in HIV/AIDS: advancing the conceptualization.

Spirig R, Moody K, Battegay M, De Geest S.

ANS Adv Nurs Sci. 2005 Oct-Dec;28(4):333-44. Review.

PMID:
16292019
19.

Improving treatment adherence in drug abusers who are HIV-positive.

Malone SB, Osborne JJ.

Lippincotts Case Manag. 2000 Nov-Dec;5(6):236-45; quiz 245-7. Review.

PMID:
16398004
20.

[HIV infection, antiretroviral therapy, and endothelium].

Hürlimann D, Weber R, Enseleit F, Lüscher TF.

Herz. 2005 Sep;30(6):472-80. Review. German.

PMID:
16170677

Supplemental Content

Support Center